Hercules, CA 11/3/14; Washington, DC 11/3/14; Washington, DC 11/3/14—Life science and diagnostics products firm Bio-Rad Laboratories has fully resolved the US Department of Justice (DOJ) and SEC investigations into violations of the Foreign Corrupt Practices Act. The violations occurred between 2005 and 2010, were related to Thailand, Vietnam and Russia, and involved both life sciences […]
In the second of IBO’s biannual reviews of new analytical-instrument and laboratory-product patent litigation (see IBO 4/30/14), the focus is on settlements and dismissals. Among the long-running disputes that have been resolved are cases involving Agilent Technologies and Illumina. New Suits GE Bio-Science filed suit against Bio-Rad Laboratories in the US District Court for the […]
Merck KGaA’s acquisition of Sigma-Aldrich for $17.0 billion ($16.3 billion net of cash) (see IBO 9/30/14) ranked among the top 10 of all US acquisitions announced year to date and set a new record for the instrument and lab-product–related industry. This transaction illustrates the continuance of consolidation for scalability and product depth among lab-consumable and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
